Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Access Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Access Pharmaceuticals

Access Pharmaceuticals

Closed

Access Pharmaceuticals: An emerging leader in oncology and diabetes, with FDA-approved treatments and ongoing trials.

HQ
Dallas, TX, US
Founded
1974
Overview
Compare
Fundraising
Employees
Website

Access Pharmaceuticals, an emerging pharmaceuticals company, was founded with a core mission to develop innovative treatments in the fields of oncology and diabetes. The company offers FDA-approved treatments, including MuGard for oral mucositis, which has been commercially launched in Europe. Additionally, Access Pharmaceuticals is advancing ProLindac, a novel DACH platinum chemotherapy, which has completed a Phase 2a trial in recurrent ovarian cancer and is set to enter combination trials. The company is actively seeking partnerships in North America while already having established collaborations in the Far East.

Notable affiliated individuals and investors have contributed to Access Pharmaceuticals' growth, though specific names are not detailed. Key achievements include the FDA approval and commercial launch of MuGard, as well as significant progress in clinical trials for ProLindac. The company's impact is marked by its commitment to addressing critical needs in oncology and diabetes treatment, positioning it as a promising player in the pharmaceutical industry.

Access Pharmaceuticals - Similar Companies

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

Moksha8 logo

Moksha8

moksha8.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

Accuitis logo

Accuitis

accuitis.com

Eagle Pharmaceuticals logo

Eagle Pharmaceuticals

eagleus.com

Elite Pharmaceuticals logo

Elite Pharmaceuticals

elitepharma.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Plumb Pharmaceuticals logo

Plumb Pharmaceuticals

plumbpharma.com

Accelerated Pharma logo

Accelerated Pharma

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Assertio Holdings logo

Assertio Holdings

Transport Pharmaceuticals logo

Transport Pharmaceuticals

Acadia Pharmaceuticals logo

Acadia Pharmaceuticals

acadia-pharm.com

Access Pharmaceuticals - Quick Facts

Who are Access Pharmaceuticals' competitors?

Companies similar to Access Pharmaceuticals include Innocrin Pharmaceuticals, Moksha8, Concours Pharmaceuticals and Panacea Pharmaceuticals.

When was Access Pharmaceuticals founded?

Access Pharmaceuticals was founded in 1974.

Where is Access Pharmaceuticals' headquarters located?

Access Pharmaceuticals' headquarters is located in Dallas, TX, US.

When was Access Pharmaceuticals' last funding round?

Access Pharmaceuticals' most recent funding round was for $10M (USD) in November 2012.

How much has Access Pharmaceuticals raised to-date?

As of Nov 6, 2012, Access Pharmaceuticals has raised a total of $38.9M (USD).

Access Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified